NCT02514447 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 32
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 123
- units
- Participants
- groups
- description
- Patients in Parts 2a and 2b were randomized 1:2 to placebo. Patients received placebo administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of placebo on Days 1 to 5, patients received IV topotecan (1.5 mg/m²). Placebos Topotecan
- id
- BG000
- title
- Placebo + Topotecan 1.5 mg/m² - Parts 2a and 2b
- description
- Patients in Part 2a were randomized 2:1 to trilaciclib. Patients received trilaciclib (240 mg/m²) administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²). Trilaciclib Topotecan
- id
- BG001
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 0.75 mg/m² - Part 2a
- description
- Patients in Part 2b were randomized 2:1 to trilaciclib. Patients received trilaciclib (240 mg/m²) administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.5 mg/m²). Trilaciclib Topotecan
- id
- BG002
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 1.5 mg/m² - Part 2b
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.50 mg/m²).
- id
- BG003
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 1.5 mg/m² - Cohort 1- Part 1
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.25 mg/m²).
- id
- BG004
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 1.25 mg/m² - Cohort 2- Part 1
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG005
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 0.75 mg/m² - Cohort 3- Part 1
- description
- Patients received trilaciclib (240 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG006
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 0.75 mg/m² - Cohorts 4 and 6- Part 1
- description
- Patients received trilaciclib (280 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG007
- title
- Trilaciclib (G1T28) 280 mg/m² + Topotecan 0.75 mg/m² - Cohort 5- Part 1
- description
- Patients received trilaciclib (240 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.0 mg/m²).
- id
- BG008
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 1.0 mg/m² - Cohort 7- Part 1
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 71
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 52
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.1
- value
- 64
- group Id
- BG001
- spread
- 8.2
- value
- 63
- group Id
- BG002
- spread
- 7.3
- value
- 62
- group Id
- BG003
- spread
- 9.2
- value
- 66
- group Id
- BG004
- spread
- 9.1
- value
- 69
- group Id
- BG005
- spread
- 6.1
- value
- 71
- group Id
- BG006
- spread
- 8.4
- value
- 62
- group Id
- BG007
- spread
- 8.9
- value
- 63
- group Id
- BG008
- spread
- 10.4
- value
- 69
- group Id
- BG009
- spread
- 8.2
- value
- 64
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 52
- title
- Female
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 71
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 121
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 7
- group Id
- BG009
- value
- 114
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 91
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 26
- title
- Serbia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- North Macedonia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- title
- Croatia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 29
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 7
- group Id
- BG009
- value
- 112
- title
- Grade 0-1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 11
- title
- Grade 2
- description
- The ECOG Performance Status Scale describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 16.37
- value
- 72.7
- group Id
- BG001
- spread
- 17.08
- value
- 71.9
- group Id
- BG002
- spread
- 17.28
- value
- 75.7
- group Id
- BG003
- spread
- 22.20
- value
- 95.2
- group Id
- BG004
- spread
- 23.59
- value
- 72.6
- group Id
- BG005
- spread
- 23.05
- value
- 90.1
- group Id
- BG006
- spread
- 29.88
- value
- 73.5
- group Id
- BG007
- spread
- 19.25
- value
- 86.3
- group Id
- BG008
- spread
- 15.00
- value
- 67.8
- group Id
- BG009
- spread
- 18.55
- value
- 74.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Weight at Screening
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.85
- value
- 166.2
- group Id
- BG001
- spread
- 9.49
- value
- 169.0
- group Id
- BG002
- spread
- 10.01
- value
- 172.2
- group Id
- BG003
- spread
- 1.27
- value
- 176.2
- group Id
- BG004
- spread
- 18.53
- value
- 169.7
- group Id
- BG005
- spread
- 5.42
- value
- 175.3
- group Id
- BG006
- spread
- 12.93
- value
- 165.2
- group Id
- BG007
- spread
- 3.49
- value
- 175.3
- group Id
- BG008
- spread
- 16.74
- value
- 167.4
- group Id
- BG009
- spread
- 10.56
- value
- 169.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height at Screening
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.239
- value
- 26.13
- group Id
- BG001
- spread
- 4.820
- value
- 25.04
- group Id
- BG002
- spread
- 5.113
- value
- 25.43
- group Id
- BG003
- spread
- 7.595
- value
- 30.72
- group Id
- BG004
- spread
- 2.430
- value
- 24.63
- group Id
- BG005
- spread
- 6.218
- value
- 29.05
- group Id
- BG006
- spread
- 7.164
- value
- 26.06
- group Id
- BG007
- spread
- 6.232
- value
- 28.11
- group Id
- BG008
- spread
- 3.502
- value
- 24.15
- group Id
- BG009
- spread
- 4.984
- value
- 25.79
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- BMI at Screening
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.234
- value
- 1.80
- group Id
- BG001
- spread
- 0.234
- value
- 1.81
- group Id
- BG002
- spread
- 0.234
- value
- 1.88
- group Id
- BG003
- spread
- 0.200
- value
- 2.11
- group Id
- BG004
- spread
- 0.398
- value
- 1.83
- group Id
- BG005
- spread
- 0.282
- value
- 2.05
- group Id
- BG006
- spread
- 0.398
- value
- 1.79
- group Id
- BG007
- spread
- 0.185
- value
- 2.01
- group Id
- BG008
- spread
- 0.274
- value
- 1.76
- group Id
- BG009
- spread
- 0.255
- value
- 1.85
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Surface Area at Screening
- unit Of Measure
- m^2
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 32
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 123
- units
- Participants
- groups
- description
- Patients in Parts 2a and 2b were randomized 1:2 to placebo. Patients received placebo administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of placebo on Days 1 to 5, patients received IV topotecan (1.5 mg/m²). Placebos Topotecan
- id
- BG000
- title
- Placebo + Topotecan 1.5 mg/m² - Parts 2a and 2b
- description
- Patients in Part 2a were randomized 2:1 to trilaciclib. Patients received trilaciclib (240 mg/m²) administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²). Trilaciclib Topotecan
- id
- BG001
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 0.75 mg/m² - Part 2a
- description
- Patients in Part 2b were randomized 2:1 to trilaciclib. Patients received trilaciclib (240 mg/m²) administered IV once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.5 mg/m²). Trilaciclib Topotecan
- id
- BG002
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 1.5 mg/m² - Part 2b
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.50 mg/m²).
- id
- BG003
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 1.5 mg/m² - Cohort 1- Part 1
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.25 mg/m²).
- id
- BG004
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 1.25 mg/m² - Cohort 2- Part 1
- description
- Patients received trilaciclib (200 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG005
- title
- Trilaciclib (G1T28) 200 mg/m² + Topotecan 0.75 mg/m² - Cohort 3- Part 1
- description
- Patients received trilaciclib (240 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG006
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 0.75 mg/m² - Cohorts 4 and 6- Part 1
- description
- Patients received trilaciclib (280 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (0.75 mg/m²).
- id
- BG007
- title
- Trilaciclib (G1T28) 280 mg/m² + Topotecan 0.75 mg/m² - Cohort 5- Part 1
- description
- Patients received trilaciclib (240 mg/m²) administered intravenously (IV) once daily on Days 1 to 5 of each 21-day topotecan chemotherapy cycle. Following administration of trilaciclib on Days 1 to 5, patients received IV topotecan (1.0 mg/m²).
- id
- BG008
- title
- Trilaciclib (G1T28) 240 mg/m² + Topotecan 1.0 mg/m² - Cohort 7- Part 1
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 71
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 52
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.1
- value
- 64
- group Id
- BG001
- spread
- 8.2
- value
- 63
- group Id
- BG002
- spread
- 7.3
- value
- 62
- group Id
- BG003
- spread
- 9.2
- value
- 66
- group Id
- BG004
- spread
- 9.1
- value
- 69
- group Id
- BG005
- spread
- 6.1
- value
- 71
- group Id
- BG006
- spread
- 8.4
- value
- 62
- group Id
- BG007
- spread
- 8.9
- value
- 63
- group Id
- BG008
- spread
- 10.4
- value
- 69
- group Id
- BG009
- spread
- 8.2
- value
- 64
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 52
- title
- Female
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 71
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 121
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 7
- group Id
- BG009
- value
- 114
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 91
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 26
- title
- Serbia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- title
- North Macedonia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- title
- Croatia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 29
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 7
- group Id
- BG009
- value
- 112
- title
- Grade 0-1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 11
- title
- Grade 2
- description
- The ECOG Performance Status Scale describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). Grade 0= Fully active, able to carry on all pre-disease performance without restriction. Grade 1= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Grade 2= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 16.37
- value
- 72.7
- group Id
- BG001
- spread
- 17.08
- value
- 71.9
- group Id
- BG002
- spread
- 17.28
- value
- 75.7
- group Id
- BG003
- spread
- 22.20
- value
- 95.2
- group Id
- BG004
- spread
- 23.59
- value
- 72.6
- group Id
- BG005
- spread
- 23.05
- value
- 90.1
- group Id
- BG006
- spread
- 29.88
- value
- 73.5
- group Id
- BG007
- spread
- 19.25
- value
- 86.3
- group Id
- BG008
- spread
- 15.00
- value
- 67.8
- group Id
- BG009
- spread
- 18.55
- value
- 74.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Weight at Screening
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.85
- value
- 166.2
- group Id
- BG001
- spread
- 9.49
- value
- 169.0
- group Id
- BG002
- spread
- 10.01
- value
- 172.2
- group Id
- BG003
- spread
- 1.27
- value
- 176.2
- group Id
- BG004
- spread
- 18.53
- value
- 169.7
- group Id
- BG005
- spread
- 5.42
- value
- 175.3
- group Id
- BG006
- spread
- 12.93
- value
- 165.2
- group Id
- BG007
- spread
- 3.49
- value
- 175.3
- group Id
- BG008
- spread
- 16.74
- value
- 167.4
- group Id
- BG009
- spread
- 10.56
- value
- 169.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height at Screening
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.239
- value
- 26.13
- group Id
- BG001
- spread
- 4.820
- value
- 25.04
- group Id
- BG002
- spread
- 5.113
- value
- 25.43
- group Id
- BG003
- spread
- 7.595
- value
- 30.72
- group Id
- BG004
- spread
- 2.430
- value
- 24.63
- group Id
- BG005
- spread
- 6.218
- value
- 29.05
- group Id
- BG006
- spread
- 7.164
- value
- 26.06
- group Id
- BG007
- spread
- 6.232
- value
- 28.11
- group Id
- BG008
- spread
- 3.502
- value
- 24.15
- group Id
- BG009
- spread
- 4.984
- value
- 25.79
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- BMI at Screening
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.234
- value
- 1.80
- group Id
- BG001
- spread
- 0.234
- value
- 1.81
- group Id
- BG002
- spread
- 0.234
- value
- 1.88
- group Id
- BG003
- spread
- 0.200
- value
- 2.11
- group Id
- BG004
- spread
- 0.398
- value
- 1.83
- group Id
- BG005
- spread
- 0.282
- value
- 2.05
- group Id
- BG006
- spread
- 0.398
- value
- 1.79
- group Id
- BG007
- spread
- 0.185
- value
- 2.01
- group Id
- BG008
- spread
- 0.274
- value
- 1.76
- group Id
- BG009
- spread
- 0.255
- value
- 1.85
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Surface Area at Screening
- unit Of Measure
- m^2
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle